Cargando…

Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Talebi Bezmin Abadi, A., Petrosillo, N., Kavoor, A.R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier España, S.L.U. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455101/ https://www.ncbi.nlm.nih.gov/pubmed/32904361 http://dx.doi.org/10.1016/j.vacun.2020.08.001

Ejemplares similares

Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains
por: Talebi Bezmin Abadi, A., et al.
Publicado: (2021)

Furazolidone and Helicobacter pylori Treatment
por: Talebi Bezmin Abadi, Amin
Publicado: (2015)

Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Mix Infections of Helicobacter pylori: A Major Risk Factor Affecting Genotyping Studies
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

Updated Helicobacter pylori Management in 2015
por: Abadi, Amin Talebi Bezmin
Publicado: (2016)

Type 2 diabetes and Helicobacter pylori infection: Starting point for the reality?
por: Abadi, Amin Talebi Bezmin
Publicado: (2015)

Comment on “Characteristics and Risk Factors of Helicobacter pylori Associated Gastritis: A Prospective Cross-Sectional Study in Northeast Thailand”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Comment on “Bacteria in Cancer Therapy: Renaissance of an Old Concept”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Comment on “Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

Call for global vaccine instead of Helicobacter pylori blind antibiotic therapy
por: Abadi, Amin Talebi Bezmin
Publicado: (2016)

Comment on “Helicobacter pylori Outer Membrane Protein 18 (Hp1125) Is Involved in Persistent Colonization by Evading Interferon-γ Signaling”
por: Talebi Bezmin Abadi, Amin, et al.
Publicado: (2015)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Rahimi, Farid, et al.
Publicado: (2019)

Transparency and information sharing could help abate the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Inefficiency of Rapid Urease Test for Confirmation of Helicobacter pylori
por: Abadi, Amin Talebi Bezmin, et al.
Publicado: (2011)

Considerable use of Furazolidone in Iran
por: Talebi Bezmin Abadi, Amin, et al.
Publicado: (2010)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

Challenges of managing the asymptomatic carriers of SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Comment on “Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms”
por: Talebi Bezmin Abadi, Amin
Publicado: (2017)

Emergence of the Delta Plus variant of SARS-CoV-2 in Iran
por: Rahimi, Farid, et al.
Publicado: (2021)

Omicron: A highly transmissible SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

Detection of the XE subvariant of SARS-CoV-2: A perspective
por: Rahimi, Farid, et al.
Publicado: (2022)

Implications of the SARS-CoV-2 subvariants BA.4 and BA.5
por: Rahimi, Farid, et al.
Publicado: (2022)

Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
por: Rahimi, Farid, et al.
Publicado: (2021)

The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2021)

A Commentary on “Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt” (Int J Surg 2022;97:106198) Contact-tracing and global vaccine equity: Crucial responses to emergence of the Omicron SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
por: Darvishi, Mohammad, et al.
Publicado: (2021)

‘The end’ – or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 subvariants
por: Rahimi, Farid, et al.
Publicado: (2023)

Corrigendum to ‘Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2’[Arch. Med. Res. 51(5) (2020) 453–454/ARCMED 2020 432]
por: Rahimi, Farid, et al.
Publicado: (2023)

Highly contagious but less severe COVID-19 caused by new SARS-CoV-2 sublineages may abate the pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

INFLUENZA VIRUS SURVEILLANCE BY THE INSTITUTO ADOLFO LUTZ, INFLUENZA SEASON 2014: ANTIVIRAL RESISTANCE
por: Santos, Katia Corrêa de Oliveira, et al.
Publicado: (2015)

Human Co-Infection with Avian and Seasonal Influenza Viruses, China
por: Li, Jun, et al.
Publicado: (2014)

Low prevalence of seasonal influenza viruses in Hong Kong, 2022
por: Mak, Gannon C. K., et al.
Publicado: (2023)

The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2021)

Clarithromycin-Susceptible But Virulent Helicobacter pylori Strains Infecting Iranian Patients’ Stomachs
por: Khani, Shadiyeh, et al.
Publicado: (2019)

Breathing Is Enough: For the Spread of Influenza Virus and SARS-CoV-2 by Breathing Only
por: Scheuch, Gerhard
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s2cl88jsfnmroqkf0t5omt25e3